MORPHOFUNCTIONAL SYSTEM CONDUIT-ARTERY IN ACUTE CORONARY SYNDROME
https://doi.org/10.17802/2306-1278-2025-14-4-123-134
Abstract
Highlights
- The analytical review proposes to consider the morphofunctional conduit-artery system in the context of acute coronary syndrome, which is one of the leading problems of modern angiology.
- Based on the data of currently available fundamental and clinical studies, possible pathophysiological scenarios are shown that potentially occur in the elements of this system.
Abstract
The review considers the autobionic morphofunctional conduit-artery system, formed surgically during coronary artery bypass grafting, including such elements as the afferent (conduit) and receiving (coronary artery) vessels, as well as blood, from the position of its functioning in conditions of an acute coronary event. For a fundamental understanding of the current status of open myocardial revascularization, which has many unresolved issues, including the timing of surgery, volume, drug therapy, etc., various pathophysiological aspects reflecting the response of the system and its elements to a vascular catastrophe are shown. In this context, new horizons are opened for further study of surgical revascularization, which will help optimize the approach to this type of treatment in patients with acute coronary syndrome.
About the Author
Aleksey V. Frolov
Federal State Budgetary Scientific Institution “Research Institute for Complex Issues of Cardiovascular Diseases”
Russian Federation
Russian Federation
Doct. of Med. Sci., Cardiovascular Surgeon, Leading Researcher of the Laboratory of Reconstructive and Interventional Surgery of Heart and Vessels, Federal State Budgetary Scientific Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation
References
1. Galzerano D., Kholaif N., Al Amro B., Al Admawi M., Eltayeb A., Alshammari A., Di Salvo G., Al-Halees Z.Y. The Ross Procedure: Imaging, Outcomes and Future Directions in Aortic Valve Replacement. J Clin Med. 2024;13(2):630. DOI: 10.3390/jcm13020630
2. Поляков А.В., Богданов С.Б., Савченко Ю.П., Фоменко О.М. Актуальность использования филатовского стебля в хирургическом лечении пациентов с ранами и рубцовыми деформациями кожи. Кубанский научный медицинский вестник. 2018;25 (1):111-116. DOI: 10.25207 / 1608-6228-2018-25-1-111-116
3. Honda K., Nishimura K., Tsujimura T., Miura M. Palatal mucoperiosteal flap for oro-nasal fistula following maxillectomy for maxillary sinus cancer. Auris Nasus Larynx. 2023;50(2):266-271. DOI: 10.1016/j.anl.2022.06.003
4. Фролов А.В. Морфофункциональная система кондуит-артерия: клинико-патофизиологическая концепция как основа эффективности аутоартериального коронарного шунтирования: дисс. … док. мед. наук. Кемерово, 2023. 388 с.
5. Ghandakly E.C., Iacona G.M., Bakaeen F.G. Coronary Artery Surgery: Past, Present, and Future. Rambam Maimonides Med J. 2024;15(1):e0001. DOI: 10.5041/RMMJ.10515
6. Mack M.J., Squiers J.J., Lytle B.W., DiMaio J.M., Mohr F.W. Myocardial Revascularization Surgery: JACC Historical Breakthroughs in Perspective. J Am Coll Cardiol. 2021 Jul 27;78(4):365-383. doi: 10.1016/j.jacc.2021.04.099. Erratum in: J Am Coll Cardiol. 2022;80(16):1582-1583. DOI: 10.1016/j.jacc.2022.09.003
7. Patlolla S.H., Crestanello J.A., Schaff H.V., Pochettino A., Stulak J.M., Daly R.C., Greason K.L., Dearani J.A., Saran N. Timing of coronary artery bypass grafting after myocardial infarction influences late survival. JTCVS Open. 2024;20:40-48. DOI: 10.1016/j.xjon.2024.05.008
8. Kirov H., Caldonazo T., Rahouma M., Robinson N.B., Demetres M., Serruys P.W., Biondi‐Zoccai G., Gaudino M., Doenst T. A systematic review and meta-analysis of percutaneous coronary intervention compared to coronary artery bypass grafting in non-ST-elevation acute coronary syndrome. Sci Rep. 2022;12:5138. DOI: 10.1038/s41598-022-09158-0
9. Farmer D., Jimenez E. Re-evaluating the Role of CABG in Acute Coronary Syndromes. Curr Cardiol Rep. 2020;22(11):148. DOI: 10.1007/s11886-020-01386-y
10. Yuan D., Chu J., Qian J., Lin H., Zhu G., Chen F., Liu X. New Concepts on the Pathophysiology of Acute Coronary Syndrome. Rev Cardiovasc Med. 2023;24(4):112. DOI: 10.31083/j.rcm2404112
11. Cecchini A., Qureshi M.H., Peshin S., Othman A., Gajjar B. Type A Aortic Dissection Presenting as Acute Coronary Syndrome in a Young Male Patient: A Case Report. Cureus. 2022;14(11):e31578. DOI: 10.7759/cureus.31578
12. Byrne R.A., Rossello X., Coughlan J.J., Barbato E., Berry C., Chieffo A., Claeys M.J., Dan G.A., Dweck M.R., Galbraith M., Gilard M., Hinterbuchner L., Jankowska E.A., Jüni P., Kimura T., Kunadian V., Leosdottir M., Lorusso R., Pedretti R.F.E., Rigopoulos A.G., Rubini Gimenez M., Thiele H., Vranckx P., Wassmann S., Wenger N.K., Ibanez B.; ESC Scientific Document Group. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720-3826. DOI: 10.1093/eurheartj/ehad191
13. Melaku L., Dabi A. The cellular biology of atherosclerosis with atherosclerotic lesion classifcation and biomarkers. Bulletin of the National Research Centre. 2021;45:225. DOI: 10.1186/s42269-021-00685-w
14. Рагино Ю.И., Волков А.М., Чернявский А.М. Стадии развития атеросклеротического очага и типы нестабильных бляшек – патофизиологическая и гистологическая характеристика. Российский кардиологический журнал. 2013;5(103):88-95. DOI: 10.15829/1560-4071-2013-5-88-95
15. Virmani R., Kolodgie F.D., Burke A.P., Farb A., Schwartz S.M. Lessons from Sudden Coronary Death a Comprehensive Morphological Classification Scheme for Atherosclerotic Lesions. Arterioscler Thromb Vasc Biol. 2000;20:1262-1275. DOI: 10.1161/01.atv.20.5.1262
16. Theofilis P., Oikonomou E., Chasikidis C., Tsioufis K., Tousoulis D. Pathophysiology of Acute Coronary Syndromes-Diagnostic and Treatment Considerations. Life (Basel). 2023;13(7):1543. DOI: 10.3390/life13071543
17. Nardin M., Verdoia M., Laera N., Cao D., De Luca G. New Insights into Pathophysiology and New Risk Factors for ACS. J Clin Med. 2023;12(8):2883. DOI: 10.3390/jcm12082883
18. Libby P. Inflammation during the life cycle of the atherosclerotic plaque. Cardiovasc Res. 2021;117(13):2525-2536. DOI: 10.1093/cvr/cvab303
19. van Veelen A., van der Sangen N.M.R., Henriques J.P.S., Claessen B.E.P.M. Identification and treatment of the vulnerable coronary plaque. Rev Cardiovasc Med. 2022;23(1):39. DOI: 10.31083/j.rcm2301039
20. Torii S., Sato Y., Otsuka F., Kolodgie F.D., Jinnouchi H., Sakamoto A., Park J., Yahagi K., Sakakura K., Cornelissen A., Kawakami R., Mori M., Kawai K., Amoa F., Guo L., Kutyna M., Fernandez R., Romero M.E., Fowler D., Finn A.V., Virmani R. Eruptive Calcified Nodules as a Potential Mechanism of Acute Coronary Thrombosis and Sudden Death. J Am Coll Cardiol. 2021;77(13):1599-1611. DOI: 10.1016/j.jacc.2021.02.016
21. Virmani R., Burke A.P., Farb A., Kolodgie F.D. Pathology of the vulnerable plaque. J Am Coll Cardiol. 2006;47(8Suppl):C13-8. DOI: 10.1016/j.jacc.2005.10.065
22. Zhang H., Dhalla N.S. The Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease. Int J Mol Sci. 2024;25(2):1082. DOI: 10.3390/ijms25021082
23. Mourouzis K., Oikonomou E., Siasos G., Tsalamadris S., Vogiatzi G., Antonopoulos A., Fountoulakis P., Goliopoulou A., Papaioannou S., Tousoulis D. Pro-inflammatory Cytokines in Acute Coronary Syndromes. Curr Pharm Des. 2020;26(36):4624-4647. DOI: 10.2174/1381612826666200413082353
24. Maaniitty E., Jalkanen J., Sinisilta S., Gunn J., Vasankari T., Biancari F., Jalkanen S., Airaksinen K.E.J., Hollmen M., Kiviniemi T. Differential circulating cytokine profiles in acute coronary syndrome versus stable coronary artery disease. Sci Rep. 2024;14(1):17269. DOI: 10.1038/s41598-024-68333-7
25. Dósa E., Rugonfalvi-Kiss S., Prohászka Z., Szabó A., Karádi I., Selmeci L., Romics L., Füst G., Acsády G., Entz L. Marked decrease in the levels of two inflammatory markers, hs-C-reactive protein and fibrinogen in patients with severe carotid atherosclerosis after eversion carotid endarterectomy. Inflamm Res. 2004;53(11):631-5. DOI: 10.1007/s00011-004-1304-y
26. Yonetsu T., Jang I.K. Cardiac Optical Coherence Tomography: History, Current Status, and Perspective. JACC Asia. 2023;4(2):89-107. DOI: 10.1016/j.jacasi.2023.10.001
27. Araki M., Sugiyama T., Nakajima A., Yonetsu T., Seegers L.M., Dey D., Lee H., McNulty I., Yasui Y., Teng Y., Nagamine T., Kakuta T., Jang I.K. Level of Vascular Inflammation Is Higher in Acute Coronary Syndromes Compared with Chronic Coronary Disease. Circ Cardiovasc Imaging. 2022;15(11):e014191. DOI: 10.1161/CIRCIMAGING.122.014191
28. Кочергин Н.А., Загородников Н.И., Фролов А.В., Тарасов Р.С., Ганюков В.И. Оптическая когерентная томография как метод оценки системы «кондуит – анастомоз – артерия» у пациентов после коронарного шунтирования. Комплексные проблемы сердечно-сосудистых заболеваний. 2022;11(4):151-157. DOI: 10.17802/2306-1278-2022-11-4-151-157
29. Bulnes J.F., González L., Velásquez L., Orellana M.P., Venturelli P.M., Martínez G. Role of inflammation and evidence for the use of colchicine in patients with acute coronary syndrome. Front Cardiovasc Med. 2024;11:1356023. DOI: 10.3389/fcvm.2024.1356023
30. Gaudino M., Di Franco A., Bhatt D.L., Alexander J.H., Abbate A., Azzalini L., Sandner S., Sharma G., Rao S.V., Crea F., Fremes S.E., Bangalore S. The association between coronary graft patency and clinical status in patients with coronary artery disease. Eur Heart J. 2021;42(14):1433-1441. DOI: 10.1093/eurheartj/ehab096
31. Salikhanov I., Koechlin L., Gahl B., Zellweger M.J., Haaf P., Müller C., Berdajs D. In-Hospital Graft Occlusion in Post-Coronary Artery Bypass Grafting Patients in the Early Postoperative Period: A Systematic Review and Meta-Analysis. J Clin Med. 2024;13(18):5514. DOI: 10.3390/jcm13185514
32. Turk T. Early graft failure after coronary artery bypass grafting: diagnosis and treatment. Eur Res J. 2016;2(2):85-92. DOI: 10.18621/eurj.2016.5000183008
33. D'Alessio A., Akoumianakis I., Kelion A., Terentes-Printzios D., Lucking A., Thomas S., Verdichizzo D., Keiralla A., Antoniades C., Krasopoulos G. Graft flow assessment and early coronary artery bypass graft failure: a computed tomography analysis. Interact Cardiovasc Thorac Surg. 2022;34(6):974-981. DOI: 10.1093/icvts/ivab298
34. Harik L., Perezgrovas-Olaria R., Soletti G. Jr., Dimagli A., Alzghari T., An K.R., Cancelli G., Gaudino M., Sandner S. Graft thrombosis after coronary artery bypass surgery and current practice for prevention. Front Cardiovasc Med. 2023;10:1125126. DOI: 10.3389/fcvm.2023.1125126
35. Gaudino M., Antoniades C., Benedetto U., Deb S., Di Franco A., Di Giammarco G., Fremes S., Glineur D., Grau J., He G.W., Marinelli D., Ohmes L.B., Patrono C., Puskas J., Tranbaugh R., Girardi L.N., Taggart D.P.; ATLANTIC (Arterial Grafting International Consortium) Alliance. Mechanisms, Consequences, and Prevention of Coronary Graft Failure. Circulation. 2017;136(18):1749-1764. DOI: 10.1161/CIRCULATIONAHA.117.027597
36. Manchio J.V., Gu J., Romar L., Brown J., Gammie J., Pierson R.N. 3rd, Griffith B., Poston R.S. Disruption of graft endothelium correlates with early failure after off-pump coronary artery bypass surgery. Ann Thorac Surg. 2005;79(6):1991-8. DOI: 10.1016/j.athoracsur.2004.12.054
37. Tseng C.N., Karlöf E., Chang Y.T., Lengquist M., Rotzius P., Berggren P.O., Hedin U., Eriksson E.E. Contribution of endothelial injury and inflammation in early phase to vein graft failure: the causal factors impact on the development of intimal hyperplasia in murine models. PLoS One. 2014;9(6):e98904. DOI: 10.1371/journal.pone.0098904
38. Mauro M.S., Finocchiaro S., Calderone D., Rochira C., Agnello F., Scalia L., Capodanno D. Antithrombotic strategies for preventing graft failure in coronary artery bypass graft. J Thromb Thrombolysis. 2024;57(4):547-557. DOI: 10.1007/s11239-023-02940-5
39. Tuzcu E.M., Hobbs R.E., Rincon G., Bott-Silverman C., De Franco A.C., Robinson K., McCarthy P.M., Stewart R.W., Guyer S., Nissen S.E. Occult and frequent transmission of atherosclerotic coronary disease with cardiac transplantation. Insights from intravascular ultrasound. Circulation. 1995;91(6):1706-13. DOI: 10.1161/01.cir.91.6.1706
40. Sandner S., Florian A., Ruel M. Coronary artery bypass grafting in acute coronary syndromes: modern indications and approaches. Curr Opin Cardiol. 2024;39(6):485-490. DOI: 10.1097/HCO.0000000000001172
41. Головина Т.С., Неверова Ю.Н., Тарасов Р.С. Аортокоронарное шунтирование в лечении пациентов с острым коронарным синдромом: современная доказательная база и не решенные вопросы. Российский кардиологический журнал. 2021;26(2):4259. DOI: 10.15829/1560-4071-2021-4259
42. Elbadawi A., Elzeneini M., Elgendy I.Y., Megaly M., Omer M., Jimenez E., Ghanta R.K., Brilakis E.S., Jneid H. Coronary artery bypass grafting after acute ST-elevation myocardial infarction. J Thorac Cardiovasc Surg. 2023;165(2):672-683.e10. DOI: 10.1016/j.jtcvs.2021.03.081
43. Lang Q., Qin C., Meng W. Appropriate Timing of Coronary Artery Bypass Graft Surgery for Acute Myocardial Infarction Patients: A Meta-Analysis. Front Cardiovasc Med. 2022;9:794925. DOI: 10.3389/fcvm.2022.794925
44. Kim H.H., Lee M., Yoo K.J. Optimal Revascularization Timing of Coronary Artery Bypass Grafting in Acute Myocardial Infarction. Clin Cardiol. 2024;47(8):e24325. DOI: 10.1002/clc.24325
45. Huckaby L.V., Sultan I., Mulukutla S., Kliner D., Gleason T.G., Wang Y., Thoma F., Kilic A. Revascularization following non-ST elevation myocardial infarction in multivessel coronary disease. J Card Surg. 2020;35(6):1195-1201. DOI: 10.1111/jocs.14539
46. Choi K.H., Song Y.B., Jeong D.S., Jang Y.H., Hong D., Lee S.Y., Youn T., Bak M., Min K.M., Lee J.M., Park T.K., Yang J.H., Hahn J.Y., Choi J.H., Choi S.H., Chung S.R., Cho Y.H., Sung K., Kim W.S., Gwon H.C., Lee Y.T. Differential effects of dual antiplatelet therapy in patients presented with acute coronary syndrome vs. stable ischaemic heart disease after coronary artery bypass grafting. Eur Heart J Cardiovasc Pharmacother. 2021;7(6):517-526. DOI: 10.1093/ehjcvp/pvaa080
47. Sandner S., Redfors B., Gaudino M. Antiplatelet therapy around CABG: the latest evidence. Curr Opin Cardiol. 2023;38(6):484-489. DOI: 10.1097/HCO.0000000000001078
48. Lawton J.S., Tamis-Holland J.E., Bangalore S., Bates E.R., Beckie T.M., Bischoff J.M., Bittl J.A., Cohen M.G., DiMaio J.M., Don C.W., Fremes S.E., Gaudino M.F., Goldberger Z.D., Grant M.C., Jaswal J.B., Kurlansky P.A., Mehran R., Metkus T.S. Jr., Nnacheta L.C., Rao S.V., Sellke F.W., Sharma G., Yong C.M., Zwischenberger B.A. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(3):e4-e17. DOI: 10.1161/CIR.0000000000001039
49. Neumann F.J., Sousa-Uva M., Ahlsson A., Alfonso F., Banning A.P., Benedetto U., Byrne R.A., Collet J.P., Falk V., Head S.J., Jüni P., Kastrati A., Koller A., Kristensen S.D., Niebauer J., Richter D.J., Seferovic P.M., Sibbing D., Stefanini G.G., Windecker S., Yadav R., Zembala M.O.; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87-165. DOI: 10.1093/eurheartj/ehy394
50. Kraler S., Libby P., Evans P.C., Akhmedov A., Schmiady M.O., Reinehr M., Camici G.G., Lüscher T.F. Resilience of the Internal Mammary Artery to Atherogenesis: Shifting From Risk to Resistance to Address Unmet Needs. Arterioscler Thromb Vasc Biol. 2021;41(8):2237-2251. DOI: 10.1161/ATVBAHA.121.316256
51. Dimitrova K.R., Hoffman D.M., Geller C.M., Dincheva G., Ko W., Tranbaugh R.F. Arterial grafts protect the native coronary vessels from atherosclerotic disease progression. Ann Thorac Surg. 2012;94(2):475-481. DOI: 10.1016/j.athoracsur.2012.04.035
52. Фролов А.В., Загородников Н.И., Тарасов Р.С., Григорьев Е.В., Иванов С.В., Барбараш Л.С. Коронаропротективный эффект внутренней грудной артерии в отдалённом послеоперационном периоде после коронарного шунтирования. Фундаментальная и клиническая медицина. 2023;8(1): 80-92. DOI: 10.23946/2500-0764-2023-8-1-80-92
53. Ostrowski S.R., Pedersen S.H., Jensen J.S., Mogelvang R., Johansson P.I. Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines. Crit Care. 2013;17(1):R32. DOI: 10.1186/cc12532
54. Mutin M., Canavy I., Blann A., Bory M., Sampol J., Dignat-George F. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood. 1999;93(9):2951-8
55. Schömig A. Catecholamines in myocardial ischemia. Systemic and cardiac release. Circulation. 1990 Sep;82(3 Suppl):II13-22
56. Basu C., Cannon P.L., Awgulewitsch C.P., Galindo C.L., Gamazon E.R., Hatzopoulos A.K. Transcriptome analysis of cardiac endothelial cells after myocardial infarction reveals temporal changes and long-term deficits. Sci Rep. 2024;14(1):9991. DOI: 10.1038/s41598-024-59155-8
57. Xenogiannis I., Zenati M., Bhatt D.L., Rao S.V., Rodés-Cabau J., Goldman S., Shunk K.A., Mavromatis K., Banerjee S., Alaswad K., Nikolakopoulos I., Vemmou E., Karacsonyi J., Alexopoulos D., Burke M.N., Bapat V.N., Brilakis E.S. Saphenous Vein Graft Failure: From Pathophysiology to Prevention and Treatment Strategies. Circulation. 2021;144(9):728-745. DOI: 10.1161/CIRCULATIONAHA.120.052163
58. He G.W. Arterial grafts: clinical classification and pharmacological management. Ann Cardiothorac Surg. 2013;2(4):507-18. DOI: 10.3978/j.issn.2225-319X.2013.07.12
59. Sugiyama K., Matsuyama K. Has the surgeon’s nightmare of graft spasm been solved? J Thorac Dis. 2024;16(7):4832-4835. DOI: 10.21037/jtd-24-185
60. Vyas V., Khan A., Singh A. Intractable Left Internal Mammary Artery Spasm After Coronary Artery Bypass Grafting. Cureus. 2020;12(2):e7045. DOI: 10.7759/cureus.7045
61. Mangana C., Lorigo M., Cairrao E. Implications of Endothelial Cell-Mediated Dysfunctions in Vasomotor Tone Regulation. Biologics. 2021;1(2):231-251. DOI: 10.3390/biologics1020015
62. Beyhoff N., Lohr D., Thiele A., Foryst-Ludwig A., Klopfleisch R., Schreiber L.M., Kintscher U. Myocardial Infarction After High-Dose Catecholamine Application-A Case Report From an Experimental Imaging Study. Front Cardiovasc Med. 2020;7:580296. DOI: 10.3389/fcvm.2020.580296
63. Fan X., Yang G., Yang Z., Uhlig S., Sattler K., Bieback K., Hamdani N., El-Battrawy I., Duerschmied D., Zhou X., Akin I. Catecholamine induces endothelial dysfunction via Angiotensin II and intermediate conductance calcium activated potassium channel. Biomed Pharmacother. 2024;177:116928. DOI: 10.1016/j.biopha.2024.116928
Supplementary files
Review
For citations:
Frolov A.V. MORPHOFUNCTIONAL SYSTEM CONDUIT-ARTERY IN ACUTE CORONARY SYNDROME. Complex Issues of Cardiovascular Diseases. 2025;14(4):123-134. (In Russ.) https://doi.org/10.17802/2306-1278-2025-14-4-123-134
Views:
9
